Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae

PHASE3CompletedINTERVENTIONAL
Enrollment

344

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Enterobacteriaceae Infections
Interventions
DRUG

Antipseudomonal beta-lactam antibiotic

Pharmaceutical form: solution for infusion

DRUG

De-escalation(short-spectrum antibiotic)

Pharmaceutical form: solution for infusion

Trial Locations (21)

11009

University Hospital Puerta del Mar, Cadiz

11138

Jerez de la Frontera Hospital, Jerez de la Frontera

20080

University Hospital Donostia, Donostia / San Sebastian

28002

University Hospital La Princesa, Madrid

28046

University Hospital La Paz, Madrid

University Hospital of Zaragoza, Zaragoza

30008

University Hospital Marqués de Valdecilla, Santander

31008

University Clinic of Navarra, Pamplona

41071

University Hospital Virgen Macarena, Seville

41930

San Juan de Dios del Aljarafe Hospital, Bormujos

Unknown

Cruces Hospital, Barakaldo

La Línea de La Concepción Hospital, La Línea de la Concepción

La Coruña Hospital, A Coruña

University Hospital of Bellvitge, Barcelona

Puerto Real Hospital, Cadiz

Universitary Hospital of Leon, León

Universitary Hospital of Orense, Ourense

Universitary Hospital of Vigo, Vigo

03012

University General Hospital of Alicante, Alicante

08221

University Hospital Mutua de Tarrasa, Barcelona

07010

Son Espases Hospital, Palma de Mallorca

All Listed Sponsors
collaborator

Spanish Network for Research in Infectious Diseases

OTHER

lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT02795949 - Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae | Biotech Hunter | Biotech Hunter